RSS Feed
Search Ask-Cato.com
Tags
adverse events biologics biomarkers biosimilar biotech cancer Cato BioVentures Cato Research CDER clinical investigator clinical research clinical trials CMC conference CROs DIA drug development eCTD efficacy FDA funding GlobalSubmit guidance Health Canada IND in vitro diagnostics manufacturing marketing application medical devices NDA NIH nonclinical research oncology Phase 1 Phase 2 PMA postmarketing protocol safety statistical analysis toxicology transparency vaccines venture capital webinarCategories
- Clinical Trials (55)
- Conferences and Meetings (35)
- eCTD (26)
- FDA (78)
- Guest Posts (5)
- Health Canada (6)
- Industry News (62)
- Project Management (1)
- Publications (7)
- Regulatory Strategy (39)
- Social Media (6)
- Statistics (9)
- Uncategorized (1)
- Venture Capital (10)
- Webinars (24)
Tag Archives: CROs
Conference Recap – BayBio 2011
The BayBio Annual Conference 2011 was held on 20-21 April 2011 in Burlingame, CA. The event was attended by more than 1,000 San Francisco Bay Area biotech and life sciences professionals from over 400 companies. This year’s conference focused on … Continue reading
Posted in Conferences and Meetings, Venture Capital
Tagged BayBio, biotech, Cato BioVentures, clinical development, CROs, drug candidate, drug development, funding, marketing, nonprofits, Northern California, Orphan Drug Designations, Phase 1, Phase 2, regulatory strategy, risk, safety, venture capital
Comments Off
India: The next up and coming location to run clinical trials?
Until recent years, clinical trials have been conducted primarily in the US and in Europe, due to higher health standards and overall standard of care for patients. However, more and more pharmaceutical companies and contract research organizations (CROs) are … Continue reading
Posted in Clinical Trials, Industry News
Tagged clinical trials, CROs, EMA, FDA, GCP, ICH, India
1 Comment
Protocol Development: Focus on the Right Objectives
Every clinical study starts with the development of a clinical protocol, a document that describes how a clinical trial is to be conducted. Clinical protocols are not only a regulatory/GCP requirement, but are absolutely essential to ensure a clinical study … Continue reading
Posted in Clinical Trials
Tagged clinical trials, CROs, ethics committee, protocol, safety
Comments Off
Clinical Trials in South Africa 101
South Africa has a mixture of both first and third world diseases and a large number of experienced research sites, making the country an excellent location for clinical trials in many indications. As we are a southern hemisphere country, recruitment … Continue reading
CRO Industry Trends
The past few years have challenged Clinical Research Organizations (CROs) to adjust their business models to meet the changing needs of pharmaceutical and biotech companies. Most CROs saw disappointing 2009 earnings, especially those focused on early stage and nonclinical research, says Scrip Clinical Research, but many mid-sized CROs saw growth in 2010. Whether CROs will be able to sustain growth in 2011 remains unclear. What we do know is that the most successful ones will be those that embrace the three major industry trends – globalization, an increased use of preferred provider relationships, and a greater willingness to invest in new technology. Continue reading
Posted in Industry News
Tagged biotech, clinical trials, CROs, CTMS, EDC, outsourcing, vendors
1 Comment
